Editas Medicine (EDIT) Retained Earnings (2015 - 2025)
Editas Medicine (EDIT) reported Retained Earnings of -$1.6 billion for Q3 2025, down 15.92% year-over-year from -$1.9 billion in Q3 2024, and down 10819320.0% quarter-over-quarter from $15000.0 in Q2 2025.
Editas Medicine (EDIT) Retained Earnings (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has 11 years of Retained Earnings data on file, last reported at -$1.6 billion in Q3 2025.
- Retained Earnings for Q3 2025 came in at -$1.6 billion, down 15.92% year-over-year; the trailing twelve-month figure through Sep 2025 was -$1.6 billion (down 15.92% YoY), and the FY2024 annual result was -$1.5 billion, down 19.25% from the prior year.
- Retained Earnings fell to -$1.6 billion in Q3 2025 per EDIT's latest filing, from $15000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $88000.0 in Q1 2025 and troughed at -$1.6 billion in Q3 2025.
- A 5-year average of -$577.2 million and a median of -$3.4 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings tumbled 1562400.0% in 2022, then soared 126.99% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$493000.0 in 2021, then sank by 218587.83% to -$1.1 billion in 2022, then declined by 14.21% to -$1.2 billion in 2023, then decreased by 19.25% to -$1.5 billion in 2024, then slipped by 10.52% to -$1.6 billion in 2025.
- Business Quant data shows EDIT's Retained Earnings at -$1.6 billion in Q3 2025, $15000.0 in Q2 2025, and $88000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Editas Medicine | 262.77 Mn | 262.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.62 Bn |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Dec 31, 2024 | -1.47 Bn |
| Sep 30, 2024 | -1.40 Bn |
| Jun 30, 2024 | -442,000.00 |
| Mar 31, 2024 | -326,000.00 |
| Dec 31, 2023 | -1.23 Bn |
| Sep 30, 2023 | -1.21 Bn |
| Jun 30, 2023 | -1.17 Bn |
| Mar 31, 2023 | -2.28 Mn |
| Dec 31, 2022 | -1.08 Bn |
| Sep 30, 2022 | -1.00 Bn |
| Jun 30, 2022 | -3.39 Mn |
| Mar 31, 2022 | -2.51 Mn |
| Dec 31, 2021 | -493,000.00 |
| Sep 30, 2021 | -64,000.00 |
| Jun 30, 2021 | -777.20 Mn |
| Mar 31, 2021 | -73,000.00 |
| Dec 31, 2020 | -46,000.00 |